Publications by authors named "Wilfried Mutombo"

Claim this Profile
T
The STROGHAT study protocol: An intervention study to evaluate safety, effectiveness and feasibility of treating gambiense HAT seropositive subjects with acoziborole.
Elena Nicco, Veerle Lejon, Erick Mwamba Miaka, Dieudonné Mumba, Alain Mpanya, Wilfried Mutombo

Open Res Eur· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study.
Ipos Ngay Lukusa, Nick Van Reet, Dieudonné Mumba Ngoyi, Erick Mwamba Miaka, Justin Masumu, Wilfried Mutombo

EBioMedicine· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study.
Andrea Kuemmerle, Caecilia Schmid, Sonja Bernhard, Victor Kande, Wilfried Mutombo

PLoS Negl Trop Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection.
Ipos Ngay Lukusa, Nick Van Reet, Dieudonné Mumba Ngoyi, Erick Mwamba Miaka, Justin Masumu, Wilfried Mutombo

PLoS Negl Trop Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Clinical Research Can Contribute to Strengthening Health Systems in Low Resource Countries.
Florent Mbo, Wilfried Mutombo, Digas Ngolo, Patrice Kabangu, Olaf Valverde Mordt

Trop Med Infect Dis· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo.
Andrea Kuemmerle, Caecilia Schmid, Victor Kande, Wilfried Mutombo, Medard Ilunga

PLoS Negl Trop Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness.
Caecilia Schmid, Andrea Kuemmerle, Johannes Blum, Salah Ghabri, Victor Kande, Wilfried Mutombo

PLoS Negl Trop Dis· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Gerardo Priotto, Serena Kasparian, Wilfried Mutombo, Daniel Ngouama, Sara Ghorashian

Lancet· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis